首页> 美国卫生研究院文献>Archives of Rheumatology >Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet’s Disease
【2h】

Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet’s Disease

机译:有效的Ankaferd止血药治疗严重的顽固性慢性深腿溃疡与Behçet病相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Ankaferd hemostat (Ankaferd Blood Stopper; ABS) is a pro-hemostatic agent affecting erythrocytes. In this article, we report a 50-year-old male patient who presented with a non-healing leg ulcer for one year. He had a past medical history of Behçet’s disease (BD) diagnosed at the age of 29 and therapy was started. Patient's leg ulcer did not respond to any treatment. Topical ABS was applied to the patient's leg ulcer daily. Our experience suggested that local treatment of ABS can be a potentially successful therapy for the management of intractable or incurable chronic ulcers in patients with BD or for other ischemic or vasculitic skin problems.
机译:Ankaferd止血剂(Ankaferd Blood Stopper; ABS)是一种影响红细胞的止血药。在本文中,我们报告了一位50岁的男性患者,该患者出现了无法治愈的腿部溃疡一年。他曾在29岁时被诊断出患有Behçet病(BD)的病史,因此开始治疗。患者的腿溃疡对任何治疗均无反应。每天将局部ABS应用于患者的腿部溃疡。我们的经验表明,局部治疗ABS可能是治疗BD患者顽固性或无法治愈的慢性溃疡或其他缺血性或血管性皮肤病的潜在成功疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号